New paper
A dual-layer computational framework for prioritising therapeutic candidates targeting extracellular vesicle-mediated immune escape in pancreatic ductal adenocarcinoma
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
CT-guided intratumoral immunotherapy for advanced solid tumors: a prospective clinical study of safety and systemic antitumor effects.
Why it was picked newest record on or before this date
New paper
Diagnostic biopsy-to-treatment interval and risk of recurrence in localized pancreatic ductal adenocarcinoma: every week counts.
Why it was picked newest record on or before this date
New paper
Generative AI–Driven Design and Experimental Validation of EGFPAN_EMBS, a Novel EGFR Inhibitor in Pancreatic Cancer
Why it was picked newest record on or before this date
New paper
ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma.
Why it was picked newest record on or before this date
Also today
New paper
Granular cell tumor of the pancreas mimicking pancreatic ductal adenocarcinoma: a case report.
New paper
Impact of initial severity and progression pattern of new-onset diabetes on pancreatic cancer risk: a 15-year longitudinal nationwide cohort study.
New paper
Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection.
New paper
Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025).
Change tracking began 4 November 2026, after this day, so only its new records are listed.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.